VIDEO: Rebyota safe, effective when given via colonoscopy for recurrent C. difficile

CHICAGO — In a Healio video exclusive, Paul Feuerstadt, MD, FACG, AGAF, discusses data showing consistent safety and efficacy of Rebyota when administered via colonoscopy for prevention of recurrent Clostridioides difficile infection.“C. difficile is a major problem for people in the United States; it is the most common health care-associated infection,” Feuerstadt, assistant clinical professor of medicine at the Yale University School of Medicine and attending gastroenterologist at the PACT Gastroenterology Center, said. “If we treat patients with totally correctRead More